Phenylbenzimidazole sulfonic acid also known as ensulizole is an organic compound largely used in sunscreens and cosmetic products worldwide. It has the ability to primarily block or absorb Ultraviolet radiations (UV). However, it doesn’t give complete protection since it is unable to block long range UV radiations; hence it is often paired with other ingredients such as avobenzone, zinc oxide, Tinosorb or titanium dioxide. Phenylbenzimidazole sulfonic acid has the characteristic quality and thus it doesn’t degrade its potency upon exposure to UV rays. Phenylbenzimidazole sulfonic acid converts incident ultraviolet radiations into less harmful infrared rays. It has a light and non-greasy finish. Phenylbenzimidazole sulfonic acid is a water soluble compound and thus it is often used in the formulation of lotions and moisturizers.
For More Industrial Insights Get PDF Brochure:
The market for Phenylbenzimidazole sulfonic acid is expected to rise in future due to rising demand for personal care products in the market. The propensity to spend on skincare is not hugely impacted by a slowdown, rather consumer preferences during this period tends to shift towards lower priced mass-market products. Personal care industry is a very large and lucrative market and thus it is expected to flourish in the near future. Hence, demand for Phenylbenzimidazole sulfonic acid is expected to grow from 2014-2020. Phenylbenzimidazole sulfonic acid is considered as a safe ingredient for use in personal care products; however the Cosmetic Databases consider it as a moderate hazard. It can cause cancer related and cellular level changes concerns if used for a prolonged period. Thus, this is hampering the growth of Phenylbenzimidazole sulfonic acid market and is the major growth barrier. Opportunity in the Phenylbenzimidazole sulfonic acid market
According to the Personal Care Products Council, phenylbenzimidazole sulfonic acid can be used in concentrations up to 8% in Europe and 4% in the U.S. The phenylbenzimidazole sulfonic acid market can be segmented on the basis of end-user industry such as- personal care, pharmacological formulations, and others. Phenylbenzimidazole sulfonic acid has been considered to be non-carcinogen by the International Agency for Research on Cancer (IARC), American Conference of Industrial Hygienists (ACGIH), the National Toxicology Program (NTP), and Occupational Safety and Health Administration (OSHA).
Request for Customization:
The phenylbenzimidazole sulfonic acid market has several players which are involved in the supply, distribution and marketing of this compound. Some of them include Shanghai Hanhong Chemical Co., Ltd., J&K Scientific Ltd., BASF SE, Sigma-Aldrich Corporation, Berje Inc, Changzhou Sunchem Pharmaceutical Chemical Material Co., Ltd., and Xiamen Hisunny Chemical Co., Ltd.